BCAT Stock Analysis: BlackRock Capital | NYSE
Asset Management | NYSE, USA | Market Cap: 1.458m USD | 12M Return: 10.8% | US09260U1097 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 12.8M
Rev. Trend: 63.9%
Warnings
Tailwinds
No distinct edge detected
Seasonality 6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
| Net Income: 222.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA -1.01 > 1.0 |
| NWC/Revenue: -93.82% < 20% (prev -100.9%; Δ 7.09% < -1%) |
| CFO/TA 0.18 > 3% & CFO 329.5m > Net Income 222.0m |
| Net Debt/EBITDA: error (cannot be calculated) |
| Current Ratio: 0.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (105.8m) vs 12m ago -1.50% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 12.18% > 50% (prev 10.59%; Δ 1.58% > 0%) |
| Interest Coverage Ratio: 155.5 > 6 (EBIT TTM 222.0m / Interest Expense TTM 1.43m) |
| A: -0.12 (Total Current Assets 7.82m - Total Current Liabilities 219.0m) / Total Assets 1.83b |
| B: 0.08 (Retained Earnings 151.8m / Total Assets 1.83b) |
| C: 0.12 (EBIT TTM 222.0m / Avg Total Assets 1.85b) |
| D: 6.23 (Book Value of Equity 1.58b / Total Liabilities 253.2m) |
| Altman-Z'' = 6.86 = AAA |
As of October 17, 2026, the stock is trading at USD 13.02 with a total of 1,569,963 shares traded. Over the past week, the price has changed by -3.31%, over one month by -6.38%, over three months by -12.26% and over the past year by +10.80%.
Current recommended Stop Loss: 12.60 (which is 3.2% or 1.7 ATR below the current price).
BlackRock Capital has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold BCAT.
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
P/E Trailing = 5.7167
P/S = 5.8406
P/B = 0.9365
Revenue TTM = 225.0m USD
EBIT TTM = 222.0m USD
EBITDA TTM = 222.0m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.45b USD (1.46b + (null Debt) - CCE 7.78m)
Interest Coverage Ratio = 155.5 (Ebit TTM 222.0m / Interest Expense TTM 1.43m)
EV/FCF = 4.40x (Enterprise Value 1.45b / FCF TTM 329.5m)
FCF Yield = 22.72% (FCF TTM 329.5m / Enterprise Value 1.45b)
FCF Margin = 146.4% (FCF TTM 329.5m / Revenue TTM 225.0m)
Net Margin = 98.65% (Net Income TTM 222.0m / Revenue TTM 225.0m)
Gross Margin = unknown ((Revenue TTM 225.0m - Cost of Revenue TTM 1.43m) / Revenue TTM)
Tobins Q-Ratio = 0.79 (Enterprise Value 1.45b / Total Assets 1.83b)
Interest Expense / Debt = unknown (Interest Expense 1.43m / Debt none)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 175.4m (EBIT 222.0m * (1 - 21.00%))
Current Ratio = 0.04 (Total Current Assets 7.82m / Total Current Liabilities 219.0m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 222.0m)
Debt / FCF = unknown (Net Debt none / FCF TTM 329.5m)
Total Stockholder Equity = 1.63b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.01% (Net Income 222.0m / Total Assets 1.83b)
RoE = 13.59% (Net Income TTM 222.0m / Total Stockholder Equity 1.63b)
RoCE = 13.78% (EBIT 222.0m / Capital Employed (Total Assets 1.83b - Current Liab 219.0m))
RoIC = 10.94% (NOPAT 175.4m / Invested Capital 1.60b)
WACC = 8.36% (E(1.46b)/V(1.46b) * Re(8.36%) + (debt-free company))
Discount Rate = 8.36% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -90.96 | Cagr: -2.34%
[DCF] Terminal Value 74.38% ; FCFF base≈339.7m ; Y1≈320.6m ; Y5≈300.1m
[DCF] Fair Price = 44.46 (EV 4.72b - Net Debt 0.0 = Equity 4.72b / Shares 106.3m; r=8.36% [WACC]; 5y FCF grow -7.15% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 63.87 | Revenue CAGR: 4.29% | SUE: N/A | # QB: 0